Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.8 EUR | -5.88% | +3.80% | -24.26% |
Apr. 30 | Emeis: sale of a real estate portfolio in the Netherlands | CF |
Apr. 30 | Orpea's Emeis Sells Dutch Nursing Home Portfolio in EUR97 Million Deal | MT |
Summary
- On the basis of various fundamental qualitative criteria, the company appears to be particularly poorly ranked from a medium and long-term investment perspective.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company appears to be poorly valued given its net asset value.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- Low profitability weakens the company.
- One of the major weak points of the company is its financial situation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
- The price targets of analysts who cover the stock differ significantly. This implies difficulties in evaluating the company and its business.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-24.26% | 2.18B | B- | ||
-0.43% | 1.4B | - | C+ | |
-27.59% | 1.36B | - | ||
+20.45% | 1.31B | B | ||
+17.49% | 711M | - | B | |
-1.82% | 467M | B- | ||
+234.37% | 414M | - | D+ | |
-9.49% | 326M | - | - | |
+5.86% | 130M | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- ORP Stock
- Ratings ORPEA